FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "RXQ Compounding, LLC(079640811)" | Midazolam | 2 mg/2 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Midazolam | 1 mg/1 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Midazolam | 1 mg/1 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Mitomycin | .2 mg/.2 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Mitomycin | .4 mg/.4 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Molybdenum | .025 mg/.025 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Morphine Sulfate | 1 mg/1 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Morphine Sulfate | 2 mg/2 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Morphine Sulfate | 5 mg/5 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Morphine Sulfate | .5 mg/.5 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Moxifloxacin Hydrochloride | 1 mg/1 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Moxifloxacin Hydrochloride | 5 mg/5 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Moxifloxacin Hydrochloride | 5 mg/5 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Naltrexone Hydrochloride | 4 mg/4 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Naltrexone Hydrochloride | 1 mg/1 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Neostigmine Methylsulfate | 1 mg/1 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Niacinamide | 100 mg/100 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Ondansetron Hydrochloride Anhydrous | 2 mg/2 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Ondansetron Hydrochloride Anhydrous | 2 mg/2 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | "niacinamide Hydriodide; Riboflavin 5'-Phosphate Sodium; Panthenol Triacetate, (+)-; Thiamine Hydrochloride; Pyridoxine Hydrochloride" | 42 mg/42 mg; 42 mg/42 mg; 42 mg/42 mg; 42 mg/42 mg; 42 mg/42 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | "niacinamide Hydriodide; Riboflavin 5'-Phosphate Sodium; Panthenol Triacetate, (+)-; Thiamine Hydrochloride; Pyridoxine Hydrochloride" | 42 mg/42 mg; 42 mg/42 mg; 42 mg/42 mg; 42 mg/42 mg; 42 mg/42 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Bevacizumab | 25 mg/25 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Bevacizumab | 25 mg/25 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Bevacizumab | 25 mg/25 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Phenylephrine Hydrochloride | .1 mg/.1 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Phenylephrine Hydrochloride; Lidocaine | 12.5 mg/12.5 mg; 12.5 mg/12.5 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Phenylephrine Hydrochloride; Lidocaine | 17.5 mg/17.5 mg; 17.5 mg/17.5 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | "niacinamide Hydriodide; Riboflavin 5'-Phosphate Sodium; Panthenol Triacetate, (+)-; Thiamine Hydrochloride; Pyridoxine Hydrochloride" | 42 mg/42 mg; 42 mg/42 mg; 42 mg/42 mg; 42 mg/42 mg; 42 mg/42 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Biotin | 1 mg/1 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Potassium Chloride | 150 mg/150 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Prednisolone Sodium Phosphate; Moxifloxacin Hydrochloride | 7.5 mg/7.5 mg; 7.5 mg/7.5 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Prilocaine Hydrochloride; Lidocaine Hydrochloride; Tetracaine | 80 mg/80 mg; 80 mg/80 mg; 80 mg/80 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Procaine Hydrochloride | 80 mg/80 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Procaine Hydrochloride | 20 mg/20 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Procaine Hydrochloride | 20 mg/20 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | "norepinephrine Hydrochloride, (+/-)-" | 8 mg/8 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Bupivacaine Hydrochloride | 1.25 mg/1.25 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Proparacaine | 5 mg/5 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Pyridoxine Hydrochloride | 100 mg/100 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Pyridoxine Hydrochloride | 100 mg/100 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Riboflavin 5'-Phosphate Sodium | 1 mg/1 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | "norepinephrine Hydrochloride, (+/-)-" | 4 mg/4 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Ropivacaine Hydrochloride | 2 mg/2 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Ropivacaine Hydrochloride; Bupivacaine Hydrochloride | 1.625 mg/1.625 mg; 1.625 mg/1.625 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Ropivacaine Hydrochloride; Bupivacaine Hydrochloride | 1.625 mg/1.625 mg; 1.625 mg/1.625 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Ropivacaine Hydrochloride; Bupivacaine Hydrochloride | .1625 mg/.1625 mg; .1625 mg/.1625 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Ropivacaine Hydrochloride; Bupivacaine Hydrochloride | 1.625 mg/1.625 mg; 1.625 mg/1.625 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | "norepinephrine Hydrochloride, (+/-)-" | 4 mg/4 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Sodium Bicarbonate | 42 mg/42 mg | 2019-1 | source_no_ndc | 2026-11-14 | ||||
| "RXQ Compounding, LLC(079640811)" | Sodium Bicarbonate | 84 mg/84 mg | 2019-1 | source_no_ndc | 2026-11-14 |